gip vs glp-1 The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism Beyond the pancreas: contrasting cardiometabolic

Together, they address the metabolic trifecta of menopausal weight gain: disrupted appetite signaling, visceral fat accumulation, and cellular energy dysfunction

PMID: 41122341

Anxiety and depression symptoms in patients with diabetes

As clinicians, recognizing that people can get double benefits from something is always helpful and as more obesity medications enter the market, this can help personalize treatments, she said

The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases